CDC: Needle Exchange Program Usage Up Significantly

Share this content:
CDC: Needle Exchange Program Usage Up Significantly
CDC: Needle Exchange Program Usage Up Significantly

WEDNESDAY, Nov. 30, 2016 (HealthDay News) -- Although there was a significant increase in the use of syringe services programs -- more commonly known as needle exchange programs -- across the United States over the past decade, many injection drug users still don't always use sterile needles, according to a Vital Signs report published in the Nov. 29 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Researchers from the CDC looked at data from injection drug users in 22 cities with high rates of HIV. In 2015, 54 percent of injection drug users said they used a needle exchange program in the past year. That was up significantly compared to the 36 percent who said they used such a program in 2005.

Despite the increased use of needle exchange programs, 33 percent of drug users in 2015 said they had shared a needle within the past year. In 2005, that number was 36 percent, according to the report. The report also highlighted progress in HIV prevention among black and Hispanic injection drug users, but uncovered worrying trends among white drug users.

The percentage of white injection drug users who said they shared syringes was 45 percent in 2005 and 43 percent in 2015. The percentage who said they received all syringes from sterile sources remained unchanged at 22 percent over the decade. HIV diagnoses among white injection drug users declined about 27 percent from 2008 to 2014. But the diagnoses remained stable from 2012 to 2014.

Full Text
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »